USV and Biogenomics launch country's first biosimilar Insulin 'Aspart'

Drug firm USV and bio-tech company Biogenomics have launched INSUQUICK, India's first biosimilar Insulin Aspart. INSUQUICK is a 'Make in India' product, developed and manufactured using indigenous technology, and has undergone rigorous clinical testing. It is now available in all metros, Tier I/II cities, and comes in cartridges,...